Skip to Main content Skip to Navigation
Journal articles

NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS

Abstract : Phenylbutyrate is used to treat inborn errors of ureagenesis, malignancies, cystic fibrosis, and thalassemia. High-dose phenylbutyrate therapy results in toxicity, the mechanism of which is unexplained. The known metabolites of phenylbutyrate are phenylacetate, phenylacetylglutamine, and phenylbutyrylglutamine. These are excreted in urine, accounting for a variable fraction of the dose. We identified new metabolites of phenylbutyrate in urine of normal humans and in perfused rat livers. These metabolites result from interference between the metabolism of phenylbutyrate and that of carbohydrates and lipids. The new metabolites fall into two categories, glucuronides and phenylbutyrate beta-oxidation side products. Two questions are raised by these data. First, is the nitrogen-excreting potential of phenylbutyrate diminished by ingestion of carbohydrates or lipids? Second, does competition between the metabolism of phenylbutyrate, carbohydrates, and lipids alter the profile of phenylbutyrate metabolites? Finally, we synthesized glycerol esters of phenylbutyrate. These are partially bioavailable in rats and could be used to administer large doses of phenylbutyrate in a sodium-free, noncaustic form.
Document type :
Journal articles
Complete list of metadata

https://hal.inrae.fr/hal-03325023
Contributor : Sabine Rossi <>
Submitted on : Tuesday, August 24, 2021 - 11:39:03 AM
Last modification on : Friday, September 3, 2021 - 9:05:23 AM

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Takhar Kasumov, Laura Brunengraber, Blandine Comte, Michelle Puchowicz, Kathryn Jobbins, et al.. NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS. Drug Metabolism and Disposition, American Society for Pharmacology and Experimental Therapeutics (ASPET), 2004, 32 (1), pp.10-19. ⟨10.1124/dmd.32.1.10⟩. ⟨hal-03325023⟩

Share

Metrics

Record views

8